Table 3.
IMPACTS primary and secondary outcomes
| Clinical and cost outcomes | Usual care (n =) | STAR program (n =) |
|---|---|---|
| Primary outcome | ||
| 30-day all-cause mortality or hospital readmission | – | – |
| Secondary outcomes | ||
| 30-day all-cause mortality | – | – |
| 30-day hospital readmission | – | – |
| 30-day sepsis/infection-related hospital readmission | – | – |
| 30-day chronic lung disease-related hospital readmission | – | – |
| 30-day heart failure-related hospital readmission | – | – |
| 30-day acute renal failure-related hospital readmission | – | – |
| 30-day emergency department visits | – | – |
| 30-day acute care-free days alive | – | – |
| 30-day acute care costs | – | – |
| 30-day total healthcare costsa | – | – |
| 90-day all-cause mortality | – | – |
| 90-day hospital readmission | – | – |
| 90-day sepsis/infection-related hospital readmission | – | – |
| 90-day chronic lung disease-related hospital readmission | – | – |
| 90-day heart failure-related hospital readmission | – | – |
| 90-day acute renal failure-related hospital readmission | – | – |
| 90-day emergency department visits | – | – |
| 90-day acute care-free days alive | – | – |
| 90-day acute care costs | – | – |
| 90-day total healthcare costsa | – | – |
IMPACTS Improving Morbidity during Post-Acute Care Transitions for Sepsis, STAR Sepsis Transition and Recovery
aOnly analyzed among Medicare-insured subgroup